Complex gene-chemical interactions: Hepatic uroporphyria as a paradigm

Chemical Research in Toxicology

Volumn 23, Issue 4, 2010, Pages 712-723

  Smith, Andrew G ^a   Elder, George H ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALCOHOL DERIVATIVE; DNA MARKER; ENZYME; HEME; HEXACHLOROBENZENE; IRON; PORPHYRIN; UROPORPHYRINOGEN DECARBOXYLASE;

GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEME SYNTHESIS; HEMOCHROMATOSIS; HEPATIC PORPHYRIA; HEREDITY; HUMAN; IRON METABOLISM; LIVER TOXICITY; MUTATION; NONHUMAN; PATHOGENESIS; PENETRANCE; PORPHYRIA CUTANEA TARDA; PORPHYRINURIA; REVIEW; SKIN DISEASE;

ANIMALS; DISEASE MODELS, ANIMAL; HEMOCHROMATOSIS; HUMANS; IRON; LIVER; MICE; PHOTOSENSITIZING AGENTS; PORPHYRIAS, HEPATIC; PORPHYRINS; TETRACHLORODIBENZODIOXIN; UROPORPHYRINOGEN DECARBOXYLASE;

ANIMALIA; MUS;

EID: 77951238118     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx900298k     Document Type: Review

References (183)

1. Nebert, D. W. and Vesell, E. S. (2004) Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead Eur. J. Pharmacol. 500, 267-280
2. Nebert, D. W., Zhang, G., and Vesell, E. S. (2008) From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions Drug Metab. Rev. 40, 187-224 (Pubitemid 352000946)
3. Ingelman-Sundberg, M., Oscarson, M., and McLellan, R. A. (1999) Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment Trends Pharmacol. Sci. 20, 342-349 (Pubitemid 29366813)
4. Meyer, U. A. and Zanger, U. M. (1997) Molecular mechanisms of genetic polymorphisms of drug metabolism Annu. Rev. Pharmacol. Toxicol. 37, 269-296 (Pubitemid 27238877)
5. Olden, K. and Wilson, S. (2000) Environmental health and genomics: visions and implications Nat. Rev. Genet 1, 149-153
6. Druesne-Pecollo, N., Tehard, B., Mallet, Y., Gerber, M., Norat, T., Hercberg, S., and Latino-Martel, P. (2009) Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer Lancet Oncol. 10, 173-180
7. Landi, S. (2009) Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature Mutat. Res. 681, 299-307
8. Blennow, K., de Leon, M. J., and Zetterberg, H. (2006) Alzheimer's disease Lancet 368, 387-403
9. Delles, C., McBride, M. W., Padmanabhan, S., and Dominiczak, A. F. (2008) The genetics of cardiovascular disease Trends Endocrinol. Metab. 19, 309-316
10. Maraganore, D. M., de Andrade, M., Lesnick, T. G., Strain, K. J., Farrer, M. J., Rocca, W. A., Pant, P. V., Frazer, K. A., Cox, D. R., and Ballinger, D. G. (2005) High-resolution whole-genome association study of Parkinson disease Am. J. Hum. Genet. 77, 685-693 (Pubitemid 41513273)
11. Myers, R. H. (2006) Considerations for genomewide association studies in Parkinson disease Am. J. Hum. Genet. 78, 1081-1082 (Pubitemid 43787700)
12. Pearson, E. R. (2008) Recent advances in the genetics of diabetes Prim. Care Diabetes 2, 67-72
13. Shih, P. A. and O'Connor, D. T. (2008) Hereditary determinants of human hypertension: strategies in the setting of genetic complexity Hypertension 51, 1456-1464
14. Ioannidis, J. P., Ntzani, E. E., Trikalinos, T. A., and Contopoulos-Ioannidis, D. G. (2001) Replication validity of genetic association studies Nat. Genet. 29, 306-309 (Pubitemid 33096456)
15. Evangelou, E., Maraganore, D. M., Annesi, G., Brighina, L., Brice, A., Elbaz, A., Ferrarese, C., Hadjigeorgiou, G. M., Krueger, R., Lambert, J. C., Lesage, S., Markopoulou, K., Mellick, G. D., Meeus, B., Pedersen, N. L., Quattrone, A., Van Broeckhoven, C., Sharma, M., Silburn, P. A., Tan, E. K., Wirdefeldt, K., and Ioannidis, J. P. (2009) Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: Large-scale collaborative study Am. J. Med. Genet., Part B 153, 220-228
16. Hunter, D. J. (2005) Gene-environment interactions in human diseases Nat. Rev. Genet. 6, 287-298
17. Khoury, M. J., Davis, R., Gwinn, M., Lindegren, M. L., and Yoon, P. (2005) Do we need genomic research for the prevention of common diseases with environmental causes? Am. J. Epidemiol. 161, 799-805 (Pubitemid 40577833)
18. Merikangas, K. R. and Risch, N. (2003) Genomic priorities and public health Science 302, 599-601 (Pubitemid 37310906)
19. Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B., and Heller, A. (2000) Concordance of the toxicity of pharmaceuticals in humans and in animals Regul. Toxicol. Pharmacol. 32, 56-67
20. Kaplowitz, N. (2005) Idiosyncratic drug hepatotoxicity Nat. Rev. Drug Discovery 4, 489-499 (Pubitemid 40861991)
21. Navarro, V. J. and Senior, J. R. (2006) Drug-related hepatotoxicity N. Engl. J. Med. 354, 731-739
22. Chung, W. H., Hung, S. I., Hong, H. S., Hsih, M. S., Yang, L. C., Ho, H. C., Wu, J. Y., and Chen, Y. T. (2004) Medical genetics: a marker for Stevens-Johnson syndrome Nature 428, 486
23. Lee, W. M. (2003) Drug-induced hepatotoxicity N. Engl. J. Med. 349, 474-485
24. Pirmohamed, M. and Park, B. K. (2001) Genetic susceptibility to adverse drug reactions Trends Pharmacol. Sci. 22, 298-305 (Pubitemid 32523913)
25. Walgren, J. L., Mitchell, M. D., and Thompson, D. C. (2005) Role of metabolism in drug-induced idiosyncratic hepatotoxicity Crit. Rev. Toxicol. 35, 325-361 (Pubitemid 40691298)
26. Andrade, R. J., Lucena, M. I., Alonso, A., Garcia-Cortes, M., Garcia-Ruiz, E., Benitez, R., Fernandez, M. C., Pelaez, G., Romero, M., Corpas, R., Duran, J. A., Jimenez, M., Rodrigo, L., Nogueras, F., Martin-Vivaldi, R., Navarro, J. M., Salmeron, J., de la Cuesta, F. S., and Hidalgo, R. (2004) HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease Hepatology 39, 1603-1612 (Pubitemid 38702661)
27. Magness, S. T., Maeda, N., and Brenner, D. A. (2002) An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyria Blood 100, 1470-1477 (Pubitemid 34864307)
28. Bonkovsky, H. L. and Lambrecht, R. W. (2000) Iron-induced liver injury Clin. Liver Dis. 4, 409-429 vi-vii
29. Hentze, M. W., Muckenthaler, M. U., and Andrews, N. C. (2004) Balancing acts: molecular control of mammalian iron metabolism Cell 117, 285-297
30. Clothier, B., Robinson, S., Akhtar, R. A., Francis, J. E., Peters, T. J., Raja, K., and Smith, A. G. (2000) Genetic variation of basal iron status, ferritin and iron regulatory protein in mice: potential for modulation of oxidative stress Biochem. Pharmacol. 59, 115-122
31. Grant, G. R., Robinson, S. W., Edwards, R. E., Clothier, B., Davies, R., Judah, D. J., Broman, K. W., and Smith, A. G. (2006) Multiple polymorphic loci determine basal hepatic and splenic iron status in mice Hepatology 44, 174-185 (Pubitemid 44049150)
32. Sassa, S. and Kappas, A. (2000) Molecular aspects of the inherited porphyrias J. Intern. Med. 247, 169-178 (Pubitemid 30108350)
33. Lankisch, T. O., Moebius, U., Wehmeier, M., Behrens, G., Manns, M. P., Schmidt, R. E., and Strassburg, C. P. (2006) Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype Hepatology 44, 1324-1332 (Pubitemid 44748383)
34. Strassburg, C. P. (2008) Pharmacogenetics of Gilbert's syndrome Pharmacogenomics 9, 703-715
35. Macklon, A. F., Savage, R. L., and Rawlins, M. D. (1979) Gilbert's syndrome and drug metabolism Clin. Pharmacokinet. 4, 223-232
36. Anderson, K. E., Sassa, S., Bishop, D. F., and Desnick, R. J. (2001) Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias, in The Metabolic and Molecular Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., and Vogelstein, B., Eds.) 8th ed., pp. 2991 - 3062, McGraw-Hill, New York.
37. Badminton, M. N. and Elder, G. H. (2005) Molecular mechanisms of dominant expression in porphyria J. Inherit. Metab. Dis. 28, 277-286 (Pubitemid 40723864)
38. Thunell, S. (2006) (Far) Outside the box: genomic approach to acute porphyria Physiol. Res. 55 (2 S43-S66
39. Whatley, S. D., Ducamp, S., Gouya, L., Grandchamp, B., Beaumont, C., Badminton, M. N., Elder, G. H., Holme, S. A., Anstey, A. V., Parker, M., Corrigall, A. V., Meissner, P. N., Hift, R. J., Marsden, J. T., Ma, Y., Mieli-Vergani, G., Deybach, J. C., and Puy, H. (2008) C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload Am. J. Hum. Genet. 83, 408-414
40. Elder, G. H. (1998) Porphyria cutanea tarda Semin. Liver Dis. 18, 67-75 (Pubitemid 28133445)
41. Elder, G. H. (2003) Porphyria cutanea tarda and related disorders, in Medical Aspects of Porphyrins (Kadish, K. M., Smith, K. M., and Guilard, R., Eds.) Vol. 14, pp. 67 - 92, Academic Press, San Diego, CA.
42. Jackson, A. H., Sancovich, H. A., Ferramola, A. M., Evans, N., Games, D. E., Matlin, S. A., Elder, G. H., and Smith, S. G. (1976) Macrocyclic intermediates in the biosynthesis of porphyrins Philos. Trans. R. Soc., B 273, 191-206
43. Phillips, J. D., Whitby, F. G., Kushner, J. P., and Hill, C. P. (1997) Characterization and crystallization of human uroporphyrinogen decarboxylase Protein Sci. 6, 1343-1346 (Pubitemid 27260169)
44. Whitby, F. G., Phillips, J. D., Kushner, J. P., and Hill, C. P. (1998) Crystal structure of human uroporphyrinogen decarboxylase EMBO J. 17, 2463-2471 (Pubitemid 28221182)
45. Phillips, J. D., Warby, C. A., Whitby, F. G., Kushner, J. P., and Hill, C. P. (2009) Substrate shuttling between active sites of uroporphyrinogen decarboxylase is not required to generate coproporphyrinogen J. Mol. Biol. 289, 306-314
46. Fracanzani, A. L., Taioli, E., Sampietro, M., Fatta, E., Bertelli, C., Fiorelli, G., and Fargion, S. (2001) Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease J. Hepatol. 35, 498-503 (Pubitemid 32964449)
47. Salata, H., Cortes, J. M., Enriquez de Salamanca, R., Oliva, H., Castro, A., Kusak, E., Carreno, V., and Hernandez Guio, C. (1985) Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors J. Hepatol. 1, 477-487 (Pubitemid 15012680)
48. Siersema, P. D., Rademakers, L. H., Cleton, M. I., ten Kate, F. J., de Bruijn, W. C., Marx, J. J., and Wilson, J. H. (1995) The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron J. Hepatol. 23, 259-267
49. Baravalle, E. and Prieto, J. (1983) Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease Gastroenterology 84, 1483-1491 (Pubitemid 13092095)
50. Aarsand, A. K., Boman, H., and Sandberg, S. (2009) Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies Clin. Chem. 55, 795-803
51. Badenas, C., To-Figueras, J., Phillips, J. D., Warby, C. A., Munoz, C., and Herrero, C. (2009) Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives Clin. Genet. 75, 346-353
52. de Verneuil, H., Nordmann, Y., Phung, N., Grandchamp, B., Aitken, G., Grelier, M., and Noire, J. (1978) Familial and sporadic porphyria cutanea: two different diseases Int. J. Biochem. 9, 927-931 (Pubitemid 9066531)
53. Christiansen, L., Bygum, A., Jensen, A., Brandrup, F., Thomsen, K., Horder, M., and Petersen, N. E. (2000) Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda Scand. J. Clin. Lab. Invest. 60, 611-615 (Pubitemid 32052520)
54. Elder, G. H. (1999) Alcohol intake and porphyria cutanea tarda Clin. Dermatol. 17, 431-436 (Pubitemid 29412936)
55. Bulaj, Z. J., Franklin, M. R., Phillips, J. D., Miller, K. L., Bergonia, H. A., Ajioka, R. S., Griffen, L. M., Guinee, D. J., Edwards, C. Q., and Kushner, J. P. (2000) Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda J. Lab. Clin. Med. 136, 482-488
56. Egger, N. G., Goeger, D. E., Payne, D. A., Miskovsky, E. P., Weinman, S. A., and Anderson, K. E. (2002) Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency Dig. Dis. Sci. 47, 419-426
57. Grossman, M. E., Bickers, D. R., Poh-Fitzpatrick, M. B., Deleo, V. A., and Harber, L. C. (1979) Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients Am. J. Med. 67, 277-286 (Pubitemid 9239524)
58. Poh-Fitzpatrick, M. B., Sosin, A. E., and Bemis, J. (1982) Porphyrin levels in plasma and erythrocytes of chronic hemodialysis patients J. Am. Acad. Dermatol. 7, 100-104 (Pubitemid 12070129)
59. Cam, C. (1960) A new epidemic dermatosis of children Ann. Dermatol. Syphiligr. (Paris) 87, 393-397
60. Cam, C. and Nigogosyan, G. (1963) Acquired toxic porphyria cutanea tarda due to hexachlorobenzene J. Am. Med. Assoc. 183, 88-91
61. Dogramaci, I., Wray, J. D., Ergene, T., Sezer, V., and Muftu, Y. (1962) Porphyria turcica, a survey of 592 cases of cutaneous porphyria seen in southeastern Turkey Turk. J. Pediatr. 4, 138-147
62. Elder, G. H. (1978) Porphyria caused by hexachlorobenzene and other polyhalogenated aromatic hydrocarbons, in Heme and Hemo-Proteins (De Matteis, F., and and Aldridge, W. N., Eds.) pp. 157 - 200, Springer-Verlag, Berlin, Germany.
63. Peters, H., Cripps, D., Gocmen, A., Bryan, G., Erturk, E., and Morris, C. (1987) Turkish epidemic hexachlorobenzene porphyria. A 30-year study Ann. N.Y. Acad. Sci. 514, 183-190 (Pubitemid 18097969)
64. Peters, H. A. (1976) Hexachlorobenzene poisoning in Turkey Fed. Proc. 35, 2400-2403
65. Schmid, R. (1960) Cutaneous porphyria in Turkey New Engl. J. Med. 263, 397-398
66. Dogramaci, I., Tinaztepe, B., and Gunalp, A. (1962) Condition of the liver in patients with toxic cutaneous porphyria Turk. J. Pediatr. 4, 103-106
67. Smith, A. G. (2003) Porphyria caused by chlorinated AH receptor ligands and associated mechanisms of liver injury and cancer, in Medical Apects of Porphyrins (Kadish, K. M., Smith, K. M., and, and Guilard, R., Eds.) Vol. 14, pp. 169 - 210, Elsevier, Amsterdam.
68. Smith, A. G. and Chernova, T. (2009) Disruption of heme synthesis by polyhalogenated aromatics, in Advances in Molecular Toxicology (Fishbein, J., Ed.) Vol. 3, pp. 169 - 218, Elsevier, Amsterdam.
69. Morley, A., Geary, D., and Harben, F. (1973) Hexachlorobenzene pesticides and porphyria Med. J. Aust. 1, 565
70. Selden, A. I., Bodin, L. S., Westberg, H., and Thunell, S. (1999) Porphyrin status in aluminium foundry workers exposed to hexachlorobenzne and octachlorostyrene Arch. Environ. Health 54, 248-253 (Pubitemid 29344874)
71. Sunyer, J., Herrero, C., Ozalla, D., Sala, M., Ribas-Fito, N., Grimalt, J., and Basagana, X. (2002) Serum organochlorines and urinary porphyrin pattern in a population highly exposed to hexachlorobenzene Environ. Health 1, 1 (Pubitemid 38957405)
72. Sunyer, J., Alvarez-Pedrerol, M., To-Figueras, J., Ribas-Fito, N., Grimalt, J. O., and Herrero, C. (2008) Urinary porphyrin excretion in children is associated with exposure to organochlorine compounds Environ. Health Perspect. 116, 1407-1410
73. Bleiberg, J., Wallen, M., Brodkin, R., and Applebaum, I. L. (1964) Industrially-acquired porphyria Arch. Derm. (Chic.) 89, 793-797
74. Boyd, A. S., Neldner, K. H., and Naylor, M. (1989) 2,3,7,8- tetrachlorodibenzo-p-dioxin-induced porphyria cutanea tarda among pediatric patients J. Am. Acad. Dermatol. 21, 1320-1321 (Pubitemid 20217028)
75. Calvert, G. M., Sweeney, M. H., Fingerhut, M. A., Hornung, R. W., and Halperin, W. E. (1994) Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin Am. J. Ind. Med. 25, 559-571
76. Jirasek, L., Kalensky, J., Kubec, K., Pazderova, J., and Lukas, E. (1976) Chloracne, porphyria cutanea tarda, and other poisonings due to the herbicides Hautarzt 27, 328-333
77. Jones, R. E. and Chelsky, M. (1986) Further discussion concerning porphyria cutanea tarda and TCDD exposure Arch. Environ. Health 41, 100-103 (Pubitemid 16072750)
78. McConnell, R., Anderson, K., Russell, W., Anderson, K. E., Clapp, R., Silbergeld, E., and Landrigan, P. (2000) Angiosarcoma, porphyria cutanea tarda, and probable chloracne in a worker exposed to waste oil contaminated with 2,3,7.,8-tetrachlorodibenzeo-p-dioxin Br. J. Indust. Med. 50, 699-703
79. Pazderova-Vejlupkova, J., Lukas, E., Nemcova, M., Pickova, J., and Jirasek, L. (1981) The development and prognosis of chronic intoxication by tetrachlordibenzo-p-dioxin in men Arch. Environ. Health 36, 5-11 (Pubitemid 11152492)
80. Caputo, R., Monti, M., Ermacora, E., Carminati, G., Gelmetti, C., Gianotti, R., Gianni, E., and Puccinelli, V. (1988) Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents. Follow-up 10 years after the Seveso, Italy, accident J. Am. Acad. Dermatol. 19, 812-819 (Pubitemid 18260988)
81. Rodriguez-Pichardo, A., Camacho, F., Rappe, C., Hansson, M., Smith, A. G., and Greig, J. B. (1991) Chloracne caused by ingestion of olive oil contaminated with PCDDs and PCDFs Hum. Exp. Toxicol. 10, 311-322
82. Chang, K. J., Lu, F. J., Tung, T. C., and Lee, T. P. (1980) Studies on patients with polychlorinated biphenyl poisoning. 2. Determination of urinary coproporphyrin, uroporphyrin, delta-aminolevulinic acid and porphobilinogen Res. Commun. Chem. Pathol. Pharmacol. 30, 547-554 (Pubitemid 11204911)
83. Colombi, A., Maroni, M., and Ferioli, A. (1982) Increase in urinary porphyrin excretion in workers exposed to polychlorinated biphenyls J. Appl. Toxicol. 2, 117-121 (Pubitemid 13178382)
84. Osterloh, J., Cone, J., Harrison, R., Wade, R., and Becker, C. (1986) Pilot survey of urinary porphyrins from persons transiently exposed to a PCB transformer fire J. Toxicol. Clin. Toxicol. 24, 533-544 (Pubitemid 17076933)
85. Strik, J. J. (1979) Porphyrins in urine as an indication of exposure to chlorinated hydrocarbons Ann. N.Y. Acad. Sci. 320, 308-310
86. De Matteis, F., Prior, B. E., and Rimington, C. (1961) Nervous and biochemical disturbances following hexachlorobenzene intoxication Nature 191, 363-366
87. Gajdos, A. and Gajdos-Török, M. (1961) The therapeutic effect of adenosine-5-monophosphoric acid in porphyria Lancet 2, 175-177
88. Kantemir, I. (1960) Porphyrin kimyasi re analiz metodlari Turk. J. Tecr. Biyol. Derg. 20
89. Ockner, R. K. and Schmid, R. (1961) Acquired porphyria in man and rat due to hexachlorobenzene intoxication Nature 189, 499
90. Strik, J. J. (1973) Chemical porphyria in Japanese quail (Coturnix c. Japonica) Enzyme 16, 211-223
91. Rimington, C. and Ziegler, G. (1963) Experimental porphyria in rats induced by chlorinated benzenes Biochem. Pharmacol. 12, 1387-1397
92. Goldstein, J. A., Hickman, P., Burse, V. W., and Bergman, H. (1975) A comparative study of two polychlorinated biphenyl mixtures (Aroclors 1242 and 1016) containing 42% chlorine on induction of hepatic porphyria and drug metabolizing enzymes Toxicol. Appl. Pharmacol. 32, 461-473
93. Gupta, B. N., McConnell, E. E., Moore, J. A., and Haseman, J. K. (1983) Effects of a polybrominated biphenyl mixture in the rat and mouse. II. Lifetime study Toxicol. Appl. Pharmacol. 68, 19-35 (Pubitemid 13128814)
94. Hill, R. H. (1985) Effects of polyhalogenated aromatic compounds on porphyria metabolism Environ. Health Perspect. 60, 139-145
95. Honda, T., Nonaka, S., Murayama, F., Ohgami, T., Shimoyama, T., and Yoshida, H. (1983) Effects of KC-400 (polychlorinated biphenyls) on porphyrin metabolism: liver and blood porphyrin analyses in rats treated with KC-400 J. Dermatol. 10, 259-265 (Pubitemid 13020214)
96. Koss, G., Meyer-Rogge, D., Seubert, S., Seubert, A., and Losekam, M. (1993) 2,2′,3′,4,4′5,5′-Hepatachlorobiphenyl (PCB 180): on its toxicokinetics, biotransformation and porphyrinogenic action in female rats Arch. Toxicol. 67, 651-654 (Pubitemid 23322943)
97. Sano, S., Kawanishi, S., and Seki, Y. (1985) Toxicity of polychlorinated biphenyl with special reference to porphyrin metabolism Environ. Health Perspect. 59, 137-143 (Pubitemid 15101719)
98. Smith, A. G., Francis, J. E., Green, J. A., Greig, J. B., Wolf, C. R., and Manson, M. M. (1990) Sex-linked hepatic uroporphyria and the induction of cytochromes P450IA in rats caused by hexachlorobenzene and polyhalogenated biphenyls Biochem. Pharmacol. 40, 2059-2068
99. Cantoni, L., Salmona, M., and Rizzardini, M. (1981) Porphyrogenic effect of chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in female rats. Dose-effect relationship following urinary excretion of porphyrins Toxicol. Appl. Pharmacol. 57, 156-163 (Pubitemid 11155151)
100. Goldstein, J. A., Linko, P., and Bergman, H. (1982) Induction of porphyria in the rat by chronic versus acute exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin Biochem. Pharmacol. 31, 1607-1613 (Pubitemid 12161781)
101. Grant, D. L., Shields, J. B., and Villeneuve, D. C. (1975) Chemical (HCB) porphyria: effect of removal of sex organs in the rat Bull. Environ. Contam. Toxicol. 14, 422-425
102. San Martin de Viale, L. C., Viale, A. A., Nacht, S., and Grinstein, M. (1970) Experimental porphyria induced in rats by hexachlorobenzene. A study of the porphyrins excreted by urine Clin. Chim. Acta 28, 13-23
103. Smith, A. G., Francis, J. E., Dinsdale, D., Manson, M. M., and Cabral, J. R. (1985) Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria Carcinogenesis 6, 631-636 (Pubitemid 15101798)
104. Smith, A. G. and Francis, J. E. (1981) Increased inhibition of hepatic uroporphyrinogen decarboxylase by hexachlorobenzene in male rats given the oestrogenic drugs diethylstilboestrol and chlorotrianisene Biochem. Pharmacol. 30, 1849-1853
105. Goldstein, J. A., Hickman, P., Bergman, H., and Vos, J. G. (1973) Hepatic porphyria induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse Res. Commun. Chem. Pathol. Pharmacol. 6, 919-928
106. Smith, A. G., Francis, J. E., Kay, S. J., and Greig, J. B. (1981) Hepatic toxicity and uroporphyrinogen decarboxylase activity following a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin to mice Biochem. Pharmacol. 30, 2825-2830
107. Sweeney, G. D., Jones, K. G., Cole, F. M., Basford, D., and Krestynski, F. (1979) Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo- p-dioxin Science 204, 332-335 (Pubitemid 9159655)
108. Smith, A. G. and Francis, J. E. (1987) Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload Biochem. J. 246, 221-226
109. Smith, A. G. and Francis, J. E. (1983) Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice Biochem. J. 214, 909-913
110. Jones, K. G. and Sweeney, G. D. (1977) Association between induction of aryl hydrocarbon hydroxylase and depression of uroporphyrinogen decarboxylase activity Res. Commun. Chem. Pathol. Pharmacol. 17, 631-637 (Pubitemid 8174334)
111. Jones, K. G. and Sweeney, G. D. (1980) Dependence of the porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo(p)dioxin upon inheritance of aryl hydrocarbon hydroxylase responsiveness Toxicol. Appl. Pharmacol. 53, 42-49
112. Davies, R., Clothier, B., Robinson, S. W., Edwards, R. E., Greaves, P., Luo, J., Gant, T. W., Chernova, T., and Smith, A. G. (2008) Essential role of the AH receptor in the dysfunction of heme metabolism induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin Chem. Res. Toxicol. 21, 330-340
113. Sinclair, P. R., Gorman, N., Walton, H. S., Bement, W. J., Dalton, T. P., Sinclair, J. F., Smith, A. G., and Nebert, D. W. (2000) CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron Toxicol. Appl. Pharmacol. 162, 60-67 (Pubitemid 30059021)
114. Smith, A. G., Clothier, B., Carthew, P., Childs, N. L., Sinclair, P. R., Nebert, D. W., and Dalton, T. P. (2001) Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin Toxicol. Appl. Pharmacol. 173, 89-98 (Pubitemid 32525708)
115. Greaves, P., Clothier, B., Davies, R., Higginson, F. M., Edwards, R. E., Dalton, T. P., Nebert, D. W., and Smith, A. G. (2005) Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: absence in the Cyp1a2(-/-) knockout mouse Biochem. Biophys. Res. Commun. 331, 147-152 (Pubitemid 40545154)
116. Gorman, N., Ross, K. L., Walton, H. S., Bement, W. J., Szakacs, J. G., Gerhard, G. S., Dalton, T. P., Nebert, D. W., Eisenstein, R. S., Sinclair, J. F., and Sinclair, P. R. (2002) Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron Hepatology 35, 912-921 (Pubitemid 34258387)
117. Felsher, B. F. and Kushner, J. P. (1977) Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect Semin. Hematol. 14, 243-251
118. Elder, G. H. (1985) Porphyria cutanea tarda and HLA-linked hemochromatosis Gastroenterology 88, 1276-1279 (Pubitemid 15087636)
119. Ippen, H. (1960) Pathogenesis and therapy of porphyria cutanea tarda (chronic hepatic porphyria). Preliminary report Klin. Wochenschr. 38, 89
120. Lundvall, O. (1971) The effect of phlebotomy therapy in porphyria cutanea tarda. Its relation to the phlebotomy-induced reduction of iron stores Acta Med. Scand. 189, 33-49
121. Rocchi, E., Gibertini, P., Cassanelli, M., Pietrangelo, A., Borghi, A., Pantaleoni, M., Jensen, J., and Ventura, E. (1986) Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion Br. J. Dermatol. 114, 621-629 (Pubitemid 16115888)
122. Alleman, M. A., Koster, J. F., Wilson, J. H., Edixhoven-Bosdijk, A., Slee, R. G., Kroos, M. J., and von Eijk, H. G. (1985) The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria Biochem. Pharmacol. 34, 161-166
123. Bach, P. H., Taljaard, J. J. F., Jouubert, S. M., and Shanley, B. C. (1971) The effect of iron overload on the development of hexachlorobenzene (HCB) porphyria S. Afr. J. Lab. Clin. Med. 17, 75-76
124. Taljaard, J. J., Shanley, B. C., Deppe, W. M., and Joubert, S. M. (1972) Porphyrin metabolism in experimental hepatic siderosis in the rat. II. Combined effect of iron overload and hexachlorobenzene Br. J. Haematol. 23, 513-519
125. Taljaard, J. J., Shanley, B. C., Deppe, W. M., and Joubert, S. M. (1972) Porphyrin metabolism in experimental hepatic siderosis in the rat. 3. Effect of iron overload and hexachlorobenzene on liver haem biosynthesis Br. J. Haematol. 23, 587-593
126. Smith, A. G., Carthew, P., Francis, J. E., Cabral, J. R., and Manson, M. M. (1993) Enhancement by iron of hepatic neoplasia in rats caused by hexachlorobenzene Carcinogenesis 14, 1381-1387 (Pubitemid 23229684)
127. Blekkenhorst, G., Day, R. S., and Eales, L. (1980) The effect of bleeding and iron administration on the development of hexachlorobenzene-induced rat porphyria Int. J. Biochem. 12, 1013-1017 (Pubitemid 11222445)
128. Wainstok de Calmanovici, R., Billi, S. C., Aldonatti, C. A., and San Martin de Viale, L. C. (1986) Effect of desferrioxamine on the development of hexachlorobenzene induced porphyria Biochem. Pharmacol. 35, 2399-2405
129. Jones, K. G., Cole, F. M., and Sweeney, G. D. (1981) The role of iron in the toxicity of 2,3,7,8-tetrachlorodibenzo-(p)-dioxin (TCDD) Toxicol. Appl. Pharmacol. 61, 74-88 (Pubitemid 11029905)
130. Franklin, M. R., Phillips, J. D., and Kushner, J. P. (2005) Attenuation of polychlorinated biphenyl induced uroporphyria by iron deprivation Environ. Toxicol. Pharmacol. 20, 417-423
131. Gorman, N., Zaharia, A., Trask, H. S., Szakacs, J. G., Jacobs, N. J., Jacobs, J. M., Balestra, D., Sinclair, J. F., and Sinclair, P. R. (2007) Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda Hepatology 46, 1927-1934 (Pubitemid 46144378)
132. Nakano, K., Ishizuka, M., Sakamoto, K. Q., and Fujita, S. (2008) Absolute requirement for iron in the development of chemically induced uroporphyria in mice treated with 3-methylcholanthrene and 5-aminolevulinate Biometals 22, 345-351
133. Greig, J. B., Francis, J. E., Kay, S. J., Lovell, D. P., and Smith, A. G. (1984) Incomplete correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin hepatotoxicity with Ah phenotype in mice Toxicol. Appl. Pharmacol. 74, 17-25
134. Smith, A. G., Clothier, B., Robinson, S., Scullion, M. J., Carthew, P., Edwards, R., Luo, J., Lim, C. K., and Toledano, M. (1998) Interaction between iron metabolism and 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene: a hepatic oxidative mechanism Mol. Pharmacol. 53, 52-61 (Pubitemid 28068372)
135. Rizzardini, M., Graziani, A., Carugo, C., and Cantoni, L. (1988) Investigations on the role of free radical processes in hexachlorobenzene- induced porphyria in mice J. Biochem. Toxicol. 3, 33-45
136. Smith, A., Cabral, J. R. P., Carthew, P., Francis, J., and Manson, M. M. (1989) Carcinogenicity of iron in conjunction with a chlorinated environmental chemical, hexachlorobenzene, in C57BL/10ScSn mice Int. J. Cancer 43, 492-496 (Pubitemid 19092334)
137. Smith, A. G., Francis, J. E., Cabral, J. R. P., Carthew, P., Manson, M. M., and Stewart, F. P. (1989) Iron-enhancement of the hepatic porphyria and cancer induced by polyhalogenated aromatic chemicals, in Free Radicals in the Pathogenesis of Liver Injury (Poli, G., Cheeseman, K. H., Dianzani, M. U., and, and Slater, T. F., Eds.) Vol. 76, pp 205 - 214, Pergamon Press, Oxford, U.K.
138. Siersema, P., van Helvoirt, R. P., Ketelaars, G. M. M., Cleton-shoeteman, M. I., Debruin, W. C., Vanijk, H., and Wilson, J. H. P. (1990) Colocalization of iron and uroporphyrin in hepatocytes of mice with hexachlorobenzene-induced porphyria Hepatology 12, 446-446
139. Khanna, R. N. and Smith, A. G. (1985) Fate of hexachlorobenzene in C57BL/10 mice with iron overload Biochem. Pharmacol. 34, 4157-4162
140. Smith, A. G., Francis, J. E., Kay, S. J., Greig, J. B., and Stewart, F. P. (1986) Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism Biochem. J. 238, 871-878
141. De Matteis, F. and Stonard, M. (1977) Experimental porphyrias as models for human hepatic porphyrias Semin. Hematol. 14, 187-192 (Pubitemid 8065365)
142. Francis, J. E. and Smith, A. G. (1987) Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL/10 mice: comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations Biochem. Biophys. Res. Commun. 146, 13-20
143. Urquhart, A. J., Elder, G. H., Roberts, A. G., Lambrecht, R. W., Sinclair, P. R., Bement, W. J., Gorman, N., and Sinclair, J. A. (1988) Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid Biochem. J. 253, 357-362
144. Smith, A. G., Francis, J. E., and Carthew, P. (1990) Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah-responsive C57BL/10ScSn mice Carcinogenesis 11, 437-444 (Pubitemid 20079397)
145. Smith, A. G. and Francis, J. E. (1993) Genetic variation of iron-induced uroporphyria in mice Biochem. J. 291, 29-35 (Pubitemid 23107745)
146. Deam, S. and Elder, G. H. (1991) Uroporphyria produced in mice by iron and 5-aminolevulinic acid Biochem. Pharmacol. 41, 2019-2022
147. d SWR mice Biochem. Pharmacol. 52, 1407-1413 (Pubitemid 26366365)
148. Phillips, J. D., Jackson, L. K., Bunting, M., Franklin, M. R., Thomas, K. R., Levy, J. E., Andrews, N. C., and Kushner, J. P. (2001) A mouse model of familial porphyria cutanea tarda Proc. Natl. Acad. Sci. U.S.A. 98, 259-264 (Pubitemid 32095897)
149. Sinclair, P. R., Gorman, N., Walton, H. S., Bement, W. J., Sinclair, J. F., Gerhard, G. S., Szakacs, J. G., Andrews, N. C., and Levy, J. E. (2001) Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda Hepatology 33, 406-412 (Pubitemid 32119029)
150. Sinclair, P. R., Gorman, N., Trask, H. W., Bement, W. J., Szakacs, J. G., Elder, G. H., Balestra, D., Sinclair, J. F., and Gerhard, G. S. (2003) Uroporphyria caused by ethanol in Hfe (-/-) mice as a model for porphyria cutanea tarda Hepatology 37, 351-358 (Pubitemid 36152534)
151. Roberts, A. G., Whatley, S. D., Morgan, R. R., Worwood, M., and Elder, G. H. (1997) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda Lancet 349, 321-323 (Pubitemid 27056825)
152. Bulaj, Z. J., Phillips, J. D., Ajioka, R. S., Franklin, M. R., Griffen, L. M., Guinee, D. J., Edwards, C. Q., and Kushner, J. P. (2000) Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda Blood 95, 1565-1571
153. Brady, J. J., Jackson, H. A., Roberts, A. G., Morgan, R. R., Whatley, S. D., Rowlands, G. L., Darby, C., Shudell, E., Watson, R., Paiker, J., Worwood, M. W., and Elder, G. H. (2000) Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda J. Invest. Dermatol. 115, 868-874
154. Jackson, H. A., Carter, K., Darke, C., Guttridge, M. G., Ravine, D., Hutton, R. D., Napier, J. A., and Worwood, M. (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors Br. J. Haematol. 114, 474-484 (Pubitemid 32762252)
155. Ajioka, R. S., Phillips, J. D., Weiss, R. B., Dunn, D. M., Smit, M. W., Proll, S. C., Katze, M. G., and Kushner, J. P. (2008) Down-regulation of hepcidin in porphyria cutanea tarda Blood 112, 4723-4728
156. Dogramaci, I., Duzgunes, O., Ergene, T., and Gocmen, A. (1962) A possible genetic factor in the etiology of porphyria Turcica Turk. J. Pediatr. 4, 193-200
157. Smith, A. G., Cabral, J. R., and De Matteis, F. (1979) A difference between two strains of rats in their liver non-haem iron content and in their response to the porphyrogenic effect of hexachlorobenzene Chem.-Biol. Interact. 27, 353-363 (Pubitemid 10157939)
158. Greig, J. B., Francis, J. E., and Smith, A. G. (1990) Genetic control of the hepatotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice Organohalogen Compd. 1, 177-180
159. Greig, J. B., Francis, J. E., Kay, S. J., Lister, T., Ray, D. E., Seawright, A. A., and Smith, A. G. (1987) Pleiotropic effect of the gene hairless on hepatotoxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in mice Arch. Toxicol. 60, 350-354
160. Robinson, S. W., Clothier, B., Akhtar, R. A., Yang, A. L., Latour, I., Van Ijperen, C., Festing, M. F., and Smith, A. G. (2002) Non-Ahr gene susceptibility loci for porphyria and liver injury induced by the interaction of 'dioxin' with iron overload in mice Mol. Pharmacol. 61, 674-681 (Pubitemid 34171934)
161. Gorman, N., Trask, H. W., Bement, W. J., Szakacs, J. G., Elder, G. H., Balestra, D., Jacobs, N. J., Jacobs, J. M., Sinclair, J. F., Gerhard, G. S., and Sinclair, P. R. (2004) Genetic factors influence ethanol-induced uroporphyria in Hfe (-/-) mice Hepatology 40, 942-950 (Pubitemid 39288128)
162. Arch, D. D., Bergeron, M., Hathaway, L., Kushner, J. P., Phillips, J. D., and Franklin, M. R. (2009) Longitudinal study of a mouse model of familial porphyria cutanea tarda Cell. Mol. Biol. (Noisy-le-Grand) 55, 46-54
163. Sen, S., Satagopan, J. M., Broman, K. W., and Churchill, G. A. (2007) R/qtlDesign: inbred line cross experimental design Mamm. Genome 18, 87-93 (Pubitemid 46425383)
164. Akhtar, R. and Smith, A. G. (1998) Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergism: a model of sporadic porphyria cutanea tarda Pharmacogenetics 8, 485-494 (Pubitemid 29043381)
165. Sinclair, P. R., Gorman, N., Dalton, T., Walton, H. S., Bement, W. J., Sinclair, J. F., Smith, A. G., and Nebert, D. W. (1998) Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice Biochem. J. 330, 149-153 (Pubitemid 28075733)
166. Uno, S., Dalton, T. P., Sinclair, P. R., Gorman, N., Wang, B., Smith, A. G., Miller, M. L., Shertzer, H. G., and Nebert, D. W. (2004) Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria Toxicol. Appl. Pharmacol. 196, 410-421 (Pubitemid 38496464)
167. Gorman, N., Walton, H. S., Bement, W. J., Honsinger, C. P., Szakacs, J. G., Sinclair, J. F., and Sinclair, P. R. (1999) Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice Biochem. Pharmacol. 58, 375-382 (Pubitemid 29255958)
168. Christiansen, L., Bygum, A., Jensen, A., Thomsen, K., Brandrup, F., Horder, M., and Petersen, N. E. (2000) Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda Hum. Genet. 107, 612-614 (Pubitemid 32010963)
169. Smith, A. G. and De Matteis, F. (1990) Oxidative injury mediated by the hepatic cytochrome P-450 system in conjunction with cellular iron. Effects on the pathway of haem biosynthesis Xenobiotica 20, 865-877 (Pubitemid 20294517)
170. Elder, G. H. and Sheppard, D. M. (1982) Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene Biochem. Biophys. Res. Commun. 109, 113-120
171. Mylchreest, E. and Charbonneau, M. (1997) Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat Toxicol. Appl. Pharmacol. 145, 23-33 (Pubitemid 27294766)
172. Elder, G. H., Urquhart, A. J., De Salamanca, R. E., Munoz, J. J., and Bonkovsky, H. L. (1985) Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda Lancet 2, 229-233
173. Mauzerall, D. and Granick, S. (1958) Porphyrin biosynthesis in erythrocytes. III. Uroporphyrinogen and its decarboxylase J. Biol. Chem. 232, 1141-1162
174. Phillips, J. D., Bergonia, H. A., Reilly, C. A., Franklin, M. R., and Kushner, J. P. (2007) A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda Proc. Natl. Acad. Sci. U.S.A. 104, 5079-5084
175. Cantoni, L., dal Fiume, D., Rizzardini, M., and Ruggieri, R. (1984) In vitro inhibitory effect on porphyrinogen carboxylyase of liver extracts from TCDD treated mice Toxicol. Lett. 20, 211--217 (Pubitemid 14178706)
176. Francis, J. E. and Smith, A. G. (1988) Oxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase FEBS Lett. 233, 311-314
177. Lin, W. and Timkovich, R. (1994) Oxygenated tetrapyrroles produced from porphyrinogens Bioorg. Chem. 22, 72-94 (Pubitemid 24172930)
178. Danton, M. and Lim, C. K. (2007) High-performance liquid chromatography/electrospray ionization tandem mass spectrometry of hydroxylated uroporphyrin and urochlorin derivatives formed by photochemical oxidation of uroporphyrinogen I Biomed. Chromatogr. 21, 534-545 (Pubitemid 46744733)
179. Lim, C. K., Danton, M., Clothier, B., and Smith, A. G. (2006) Dihydroxy-, hydroxyspirolactone-, and dihydroxyspirolactone-urochlorins induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the liver of mice Chem. Res. Toxicol. 19, 1660-1667 (Pubitemid 44975129)
180. Smith, A. G., Francis, J. E., and Greig, J. B. (1985) Continued depression of hepatic uroporphyrinogen decarboxylase activity caused by hexachlorobenzene or 2,3,7,8-tetrachlorodibenzo- p -dioxin despite regeneration after partial hepatectomy Biochem. Pharmacol 34, 1817-1820
181. De Matteis, F. (1988) Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): a possible mechanism for the exacerbation by iron of hepatic uroporphyria Mol. Pharmacol. 33, 463-469
182. Gorman, N., Zaharia, A., Track, H. S., Szakacs, J. G., Jacobs, N. J., Jacobs, J. M., Balestra, D., Sinclair, J. F., and Sinclair, P. R. (2007) Effect of iron and ascorbate on uroporphyria in ascorbate-requiring mice as a model for porphyria cutanea tarda Hepatology 45, 187-194 (Pubitemid 46144378)
183. Rowley, B. and Sweeney, G. D. (1984) Release of ferrous iron from ferritin by liver microsomes: a possible role in the toxicity of 2,3,7,8-tetrachlorodibenzo- p -dioxin Can. J. Biochem. Cell Biol. 62, 1293-1300 (Pubitemid 15119497)